Cross-Sector entity
Of the tracked stories, 11 of 20 also mention Weiss Ratings, the most common co-covered peer. That works out to roughly 0.9 stories per week across a 148-day span. The busiest single day carried 3. The clearest coverage concentration is earnings: 5 of 20 stories, with the rest divided among 10 other categories.
23 verified stories tracked
Last mentioned: Aug 16, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Of the tracked stories, 11 of 20 also mention Weiss Ratings, the most common co-covered peer. That works out to roughly 0.9 stories per week across a 148-day span. The busiest single day carried 3. The clearest coverage concentration is earnings: 5 of 20 stories, with the rest divided among 10 other categories. This profile follows 20 Cross-Sector stories mentioning Jefferies Financial Group across the period from March 22, 2026 to August 16, 2026. The tracked stories average 2 original sources each. 0% of these stories carry negative sentiment.
Computed from the 20 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Jefferies Financial Group. Shared-story counts are live from our verified record — not editorial picks.
Wells Fargo Cuts Target to $70
Wells Fargo & Company lowers Freshpet’s price target from $75.00 to $70.00, keeping an Overweight rating, implying 28.42% upside.
Bank of America Lowers Target
Bank of America reduces its price target from $75.00 to $70.00 and maintains a Neutral rating.
Piper Sandler Stays Overweight
Piper Sandler reaffirms an Overweight rating on Freshpet shares.
Weiss Ratings Downgrades
Weiss Ratings cuts Freshpet from 'Hold (c)' to 'Hold (c-)'.
JPMorgan Upgrades, Others Reaffirm
JPMorgan raises rating from Neutral to Overweight and lifts target from $66.00 to $68.00. Morgan Stanley reiterates Overweight with $77.00 target, while Deutsche Bank holds at Hold with $63.00 target.
Jefferies Cuts Target
Jefferies Financial Group lowers its price objective from $75.00 to $70.00 and maintains a Hold rating.
TD Cowen Turns Bullish
TD Cowen upgrades Freshpet from Hold to Buy and sets an $80.00 price objective.
Oppenheimer Upgrades Freshpet
Oppenheimer raises Freshpet from Market Perform to Outperform with an $80.00 price target.
Single-family rental REIT American Homes 4 Rent has a modestly reduced $38 price target from Morgan Stanley, still above a $36.78 consensus and leaving 11% upside. The maintained Overweight rating reinforces the resilience of the SFR asset class amid housing supply constraints.
Morgan Stanley trimmed its American Homes 4 Rent target to $38 from $38.50 while keeping an Overweight rating, against a $36.78 consensus and Moderate Buy average. Equity research actions from Jefferies, UBS, RBC, Mizuho, and Compass Point reveal a broadly constructive but price-sensitive stance on the REIT.
Source: themarketsdaily.com · tickerreport.com
Spyglass Pharma's stock plunges to a new 52-week low of $17.56 despite a consensus 'Moderate Buy' rating and an average analyst target of $45. For biotech investors, the 156% upside potential must be weighed against a recent earnings miss and a downgrade to sell, raising questions about near-term pipeline catalysts.
Source: tickerreport.com · dailypolitical.com
BARK's quarterly earnings impressed with $0.08 EPS, crushing the -$0.40 estimate on $78.81M revenue. The pet subscription company's stock jumped 22.8% as improving unit economics hint at a retail turnaround.
BARK delivered a surprise $0.08 EPS, beating estimates by $0.48, sending its battered stock up to $11.25. With a $101.6M market cap and a consensus target of $15.33, the high-beta small-cap is drawing both institutional and retail interest.
Source: themarketsdaily.com · dailypolitical.com
EPAM Systems' Q3 EPS guidance of up to $3.46 topped consensus by 3.9%, while full-year profit view surged to $13.24, handily beating the $12.53 consensus. Despite a flat revenue outlook, the firm's improved profitability signals strong cost controls and could spark a re-rating of its discounted stock, now trading at 15.7x earnings.
Source: Ticker Report · Zolmax
CBRE Group's above-consensus EPS guidance underscores the commercial real estate sector's momentum, driven by technology-driven services. For PropTech startups and investors, it signals growing client spending on smart buildings, data analytics, and digital brokerage platforms.
Teva Pharmaceutical's FY2026 EPS guidance fell short of the $2.17 consensus, while revenue projections of $16.5-$16.9B matched expectations. For healthcare leaders, the miss underscores ongoing generic drug pricing pressures and the importance of a diversified pipeline.
Teva's fiscal 2026 EPS guidance, well below the Street's $2.17, raises red flags for biotech and pharma investors. However, a $42 average price target and stable revenue suggest a value play if the biosimilar pipeline delivers.
Source: tickerreport.com · themarketsdaily.com
Bloom Energy shares popped 6.5% on 46% higher volume to $219.22, reigniting the debate about its $62.36B valuation amid a bull-bear analyst divide. With price targets spanning $188 to $310 and a P/E near 292, the AI-driven stock offers high risk and high potential reward.
Bloom Energy's 6.5% stock surge reflects market conviction that its fuel cells will power the AI data center boom. With a $62.36B market cap and raised annual guidance, the company is cementing itself as a critical clean energy infrastructure provider, but legal risks and high valuation loom.
Source: MarketBeat · dailypolitical.com
Nayax shares jumped 4.7% on Monday after a series of analyst upgrades, despite a Q1 earnings miss. With a market cap of $2.47 billion and a rich P/E of 85, the cashless payment provider for unattended retail faces both secular tailwinds and profitability scrutiny. Consensus price target stands at $78.16, offering 15.9% upside.
TeraWulf Inc. surged 7% on Monday to $19.43 after multiple analyst upgrades, even after a massive Q1 EPS miss. With a $9.45 billion market cap and a sky-high debt-to-equity ratio of 33, the Bitcoin miner’s stock is a pure play on crypto momentum, as consensus targets reach $34.60 and one analyst calls for $40.
Source: tickerreport.com · dailypolitical.com
Wabtec guided revenue between $12.3-$12.6B and EPS slightly below the Street, while Moody’s EPS range also came in under estimates. Analysts remain constructive with moderate buy ratings and double-digit upside targets for both stocks.
Source: Bbns · Markets Daily
Monarch Casino & Resort posted a second-quarter earnings beat of $0.11 per share on revenue strength, driving the stock up 1.1% to $124.38. Valuation metrics remain solid with a P/E of 21.08 and a 1% dividend yield, but a recent CEO stock sale and mixed analyst ratings signal a cautious bias. Truist’s $144 price target offers the most bullish outlook, while Stifel sits at $102.
Source: MarketBeat · tickerreport.com
Wells Fargo lowered its price target on Freshpet to $70 from $75 while maintaining an Overweight rating, implying the stock is undervalued by 28%. The market remains skeptical with FRPT trading at $54.51, well below the consensus analyst target of $74.25. Analysts overall rate the pet food company a Moderate Buy, despite a string of recent target cuts.
Source: Watch List News · Ticker Report
While the AI infrastructure boom is driving U.S. economic growth to 5.9% nominal GDP, it’s also fueling inflation that could force the Fed to hike rates by 36bp. Higher borrowing costs may squeeze venture capital flows, but AI startups might still ride the spending wave.
A new Jefferies report warns that the massive AI infrastructure buildout is keeping U.S. inflation elevated, forcing markets to price in further rate hikes. Two-year Treasury yields just saw their biggest one-day jump in 14 months, and money markets now expect 36 basis points of tightening by year-end.
Jefferies’ latest research reveals that the AI capex arms race is the main engine behind 5.9% nominal GDP growth, but it is simultaneously pushing CPI to a three-year high. The sector’s breakneck buildout is reshaping monetary policy expectations and the funding landscape for AI ventures.
Source: devdiscourse.com · lokmattimes.com
Zacks Research has issued rare 'Strong Sell' ratings for both Australian mining giant Fortescue and French luxury conglomerate Kering. The downgrades highlight deepening concerns over earnings estimate revisions and the companies' heavy exposure to a cooling Chinese economy.
Source: The Lincolnian Online · Bbns
